Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Else

Showing results (31-40 of 135) with videos related to

Pageof 14
Sort By:
Circulation|June 2, 2017
Age-Related Autonomous AldosteronismKazutaka Nanba, Anand Vaidya, Gordon H Williams, et al.
JAAD Case Reports|May 4, 2019
A few pink papules in an adult woman: Incidental finding leads to diagnosis of hereditary leiomyomatosis and renal cell cancerKelly Z Young, Tom D Raisanen, Tobias Else, et al.
Pediatric Blood & Cancer|August 29, 2025
Successful Use of Targeted HIF-2α Inhibition in EPAS1-Mutated Congenital ErythrocytosisElliot Ensink, Tobias Else, Mark Hannibal, et al.
JAAD Case Reports|August 27, 2024
Incidental melanoma and thyroid cancer lead to diagnosis of Lynch syndrome and endometrial cancer: A case reportMolly E Kuo, Emily H Smith, Jaclyn Plotzke, et al.
The Journal of Clinical Endocrinology and Metabolism|December 5, 2013
Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinomaTobias Else, Andrew R Williams, Aaron Sabolch, et al.
The Journal of Pathology|January 17, 2024
Spatial profiling reveals tissue-specific neuro-immune interactions in gastroenteropancreatic neuroendocrine tumorsSuzann Duan, Travis W Sawyer, Brandon L Witten, et al.
Cancers|February 10, 2024
Novel Approaches with HIF-2α Targeted Therapies in Metastatic Renal Cell CarcinomaCharles B Nguyen, Eugene Oh, Piroz Bahar, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 20, 2021
American Association of Clinical Endocrinology Disease State Clinical Review on the Evaluation and Management of Adrenocortical Carcinoma in an Adult: a Practical ApproachKatja Kiseljak-Vassiliades, Irina Bancos, Amir Hamrahian, et al.
American Journal of Cancer Research|February 13, 2023
The spectrum of clinical and genetic findings in hereditary leiomyomatosis and renal cell cancer (HLRCC) with relevance to patient outcomes: a retrospective study from a large academic tertiary referral centerThomas Scharnitz, Mio Nakamura, Erika Koeppe, et al.
Endocrine Oncology (Bristol, England)|October 23, 2025
Success of <sup>177</sup>Lu-DOTATATE therapy in a metastatic pituitary neuroendocrine tumorKatherine I Wolf, Zhonglin Lu, Elizabeth A Hesseltine, et al.
Pageof 14

Showing results (31-40 of 135) with videos related to

Sort By:
Pageof 14
Circulation|June 2, 2017
Age-Related Autonomous AldosteronismKazutaka Nanba, Anand Vaidya, Gordon H Williams, et al.
JAAD Case Reports|May 4, 2019
A few pink papules in an adult woman: Incidental finding leads to diagnosis of hereditary leiomyomatosis and renal cell cancerKelly Z Young, Tom D Raisanen, Tobias Else, et al.
Pediatric Blood & Cancer|August 29, 2025
Successful Use of Targeted HIF-2α Inhibition in EPAS1-Mutated Congenital ErythrocytosisElliot Ensink, Tobias Else, Mark Hannibal, et al.
JAAD Case Reports|August 27, 2024
Incidental melanoma and thyroid cancer lead to diagnosis of Lynch syndrome and endometrial cancer: A case reportMolly E Kuo, Emily H Smith, Jaclyn Plotzke, et al.
The Journal of Clinical Endocrinology and Metabolism|December 5, 2013
Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinomaTobias Else, Andrew R Williams, Aaron Sabolch, et al.
The Journal of Pathology|January 17, 2024
Spatial profiling reveals tissue-specific neuro-immune interactions in gastroenteropancreatic neuroendocrine tumorsSuzann Duan, Travis W Sawyer, Brandon L Witten, et al.
Cancers|February 10, 2024
Novel Approaches with HIF-2α Targeted Therapies in Metastatic Renal Cell CarcinomaCharles B Nguyen, Eugene Oh, Piroz Bahar, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 20, 2021
American Association of Clinical Endocrinology Disease State Clinical Review on the Evaluation and Management of Adrenocortical Carcinoma in an Adult: a Practical ApproachKatja Kiseljak-Vassiliades, Irina Bancos, Amir Hamrahian, et al.
American Journal of Cancer Research|February 13, 2023
The spectrum of clinical and genetic findings in hereditary leiomyomatosis and renal cell cancer (HLRCC) with relevance to patient outcomes: a retrospective study from a large academic tertiary referral centerThomas Scharnitz, Mio Nakamura, Erika Koeppe, et al.
Endocrine Oncology (Bristol, England)|October 23, 2025
Success of <sup>177</sup>Lu-DOTATATE therapy in a metastatic pituitary neuroendocrine tumorKatherine I Wolf, Zhonglin Lu, Elizabeth A Hesseltine, et al.
Pageof 14